National Institute of Allergy and Infectious Diseases, Notice of Closed Meetings, 346-347 [06-9970]

Download as PDF mstockstill on PROD1PC61 with NOTICES 346 Federal Register / Vol. 72, No. 2 / Thursday, January 4, 2007 / Notices Court of Federal Claims Number 06–0618V 37. Debbie Squire on behalf of Tyrese Campbell, Philadelphia, Pennsylvania, Court of Federal Claims Number 06–0619V 38. Belisario Bolanos, San Bernadino, California, Court of Federal Claims Number 06–0621V 39. Janice Ferro, New York, New York, Court of Federal Claims Number 06–0625V 40. Jimmie Lee Lazenberry on behalf of Betty Lazenberry, Jacksonville, Florida, Court of Federal Claims Number 06–0630V 41. Jimmie Lee Lazenberry on behalf of Henry Lazenberry, Jacksonville, Florida, Court of Federal Claims Number 06–0631V 42. Jimmie Lee Lazenberry on behalf of Ricky Lazenberry, Jacksonville, Florida, Court of Federal Claims Number 06–0632V 43. Maria Lynch on behalf of Anna Lynch, Vienna, Virginia , Court of Federal Claims Number 06–0634V 44. Clair Swaiss, Boston, Massachusetts, Court of Federal Claims Number 06–0638V 45. Osama Elgebaly on behalf of Yusra Elgebaly, Boston, Massachusetts, Court of Federal Claims Number 06–0639V 46. Julissa and Emiliano Aguero on behalf of Emiliano G. Aguero, Fort Lee, New Jersey, Court of Federal Claims Number 06–0642V 47. Stephanie and Clifton Miller on behalf of Kharisa Miller, Boston, Massachusetts, Court of Federal Claims Number 06–0643V 48. Nicole Morris on behalf of Grace Morris, Deceased, Morris, Illinois, Court of Federal Claims Number 06–0644V 49. Nella and James Coe on behalf of Isabella Coe, Portland, Oregon, Court of Federal Claims Number 06–0645V 50. Mirielle Chapa on behalf of Oscar Chapa, Somers Point, New Jersey, Court of Federal Claims Number 06–0647V 51. Tiffani Peacock on behalf of Morgan Peacock, Apple Valley, California, Court of Federal Claims Number 06–0649V 52. Mitch Anderson, Quincy, Massachusetts, Court of Federal Claims Number 06–0650V 53. Christine Saddler on behalf of Daniel Saddler, Eagle River, Alaska, Court of Federal Claims Number 06–0657V 54. Rebecca and Gregory Schwartz on behalf of Nathan Schwartz, Birmingham, Alabama, Court of Federal Claims Number 06–0662V VerDate Aug<31>2005 15:51 Jan 03, 2007 Jkt 211001 55. Bridgette Bigbee and Royce Carter on behalf of Kaleaf Carter, Deceased, Richmond, California, Court of Federal Claims Number 06–0663V 56. Douglas Henning, Jacksonville, Florida, Court of Federal Claims Number 06–0665V 57. Jennifer Stammer, Edmond, Oklahoma, Court of Federal Claims Number 06–0667V 58. Cristal DeBlasis, Philadelphia, Pennsylvania, Court of Federal Claims Number 06–0669V 59. Antoinette Chin, Harrington Park, New Jersey, Court of Federal Claims Number 06–0670V 60. Melissa and Paul Follett on behalf of Aidan Drakose Exavier Follett, Deceased, Greenville, Michigan, Court of Federal Claims Number 06–0671V 61. Christine Bitenieks on behalf of Donovan Bitenieks, Lincoln, Nebraska, Court of Federal Claims Number 06–0673V 62. Ana and Hugo Solano on behalf of Allen Solano, Elizabeth, New Jersey, Court of Federal Claims Number 06–0674V 63. Tracy Perl on behalf of Andrew Perl, Vienna, Virginia, Court of Federal Claims Number 06–0678V 64. Tracy and Brent Dallman on behalf of Luke Dallman, Indianapolis, Indiana, Court of Federal Claims Number 06–0679V Dated: December 22, 2006. Elizabeth M. Duke, Administrator. [FR Doc. E6–22507 Filed 1–3–07; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Research Resources; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Research Resources Special Emphasis Panel, Wisconsin NPRC. Date: January 24–26, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: The Madison Concourse Hotel and Governor’s Club, One West Dayton Street, Madison, WI 53703. Contact Person: Carol Lambert, PhD, Scientific Review Administrator, Office of Review, National Center For Research Resources, National Institutes of Health, 6701 Democracy Blvd. 1 Dem. Plaza, Room 1076, Bethesda, MD 20892, (301) 435–0814, lambert@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine, 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure, 93.306, 93.333, National Institutes of Health, HHS) Dated: December 26, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–9971 Filed 1–3–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases, Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Cooperative Research Patnerships for Influenza Product Development. Date: January 24–25, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Silver Spring, 8727 Colesville Road, Silver Spring, MD 20910. E:\FR\FM\04JAN1.SGM 04JAN1 mstockstill on PROD1PC61 with NOTICES Federal Register / Vol. 72, No. 2 / Thursday, January 4, 2007 / Notices Contact Person: Clayton C. Huntley, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, Room 3246, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, (301) 451–2570 ch405t@nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Study of Antigen Presentation Unsolicited P01. Date: January 25, 2007. Time: 10 a.m. to 1 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Cheryl K. Lapham, PhD, Scientific Review Administrator, Scientific Review Program, National Institute of Allergy and Infectious Diseases, DEA/NIH/DHHS, 6700–B Rockledge Drive, MSC 7616, Room 3127, Bethesda, MD 20892–7616, 301–402– 4598, Clapham@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Cooperative Research Partnerships for Influenza Product Development. Date: January 29–30, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Silver Spring, 8727 Colesville Road, Silver Spring, MD 20910. Contact Person: Clayton C. Huntley, Phd, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, Room 3246, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 2089–7616, (301) 451–2570, ch405t@nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Study of Immunoregulation Unsolicited P01. Date: February 7, 2007. Time: 12 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Cheryl K. Lapham, PhD, Scientific Review Administrator, Scientific Review Program, National Institute of Allergy and Infectious Diseases, DEA/NIH/DHHS, 6700–B Rockledge Drive MSC 7616, Room 3127, Bethesda, MD 20892–7616, 301–402– 4598, clapham@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Safety Evaluation of AntiInfective Agents. Date: February 12, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: Bethesda North Marriot Hotel, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Quirijn Vos, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural VerDate Aug<31>2005 15:51 Jan 03, 2007 Jkt 211001 Activities, National Institutes of Health/ NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–496–2550, qvos@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: December 26, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–9970 Filed 1–3–07; 8:45 am] BILLING CODE 4140–01–M 347 Center Drive, Room 5B–05, Bethesda, MD 20892–2178, 301/496–8230, Kerrme@mail.nih.gov. Information is also available on the Institute’s/Center’s home page: www.nih.gov/ ninr/a_advisory.html, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.361, Nursing Research, National Institutes of Health, HHS) Dated: December 26, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–9972 Filed 1–3–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health DEPARTMENT OF HOMELAND SECURITY National Institute of Nursing Research; Notice of Meeting Coast Guard Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Institute of Nursing Research. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Nursing Research. Date: January 23–24, 2007. Open: January 23, 2007, 1 p.m. to 5 p.m. Agenda: Discussion of Program Policies and Issues. Place: National Institutes of Health, Building 31, 31 Center Drive, Conf. 6C10, Bethesda, MD 20892. Closed: January 24, 2007, 9 a.m. to Adjournment. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conf. 6C10, Bethesda, MD 20892. Contact Person: Mary E. Kerr, FAAN, RN, PhD, Deputy Director, National Institute of Nursing, National Institutes of Health, 31 PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 [COTP Corpus Christi–06–096] South Texas Area Maritime Security (STAMS) Committee; Vacancies Coast Guard, DHS. Notice. AGENCY: ACTION: SUMMARY: This notice requests individuals interested in serving on the South Texas Area Maritime Security (STAMS) Committee to submit their application for membership, effective February 26, 2007, to the Corpus Christi Captain of the Port/Federal Maritime Security Coordinator. DATES: Requests for membership should reach the Corpus Christi Captain of the Port/Federal Maritime Security Coordinator on or before February 15, 2007. Requests for membership should be submitted to the Captain of the Port/Federal Maritime Security Coordinator at the following address: Commander, USCG Sector Corpus Christi, 8930 Ocean Drive, Hangar 41, Corpus Christi, Texas 78419. FOR FURTHER INFORMATION CONTACT: Mr. John Zarbock at 361–888–3162 (x501). SUPPLEMENTARY INFORMATION: ADDRESSES: Authority Section 102 of the Maritime Transportation Security Act (MTSA) of 2002 (Pub. L. 107–295) added section 70112 to Title 46 of the U.S. Code, and authorized the Secretary of the Department in which the Coast Guard is operating to establish Area Maritime Security Committees for any port area of the United States. (See 33 U.S.C. 1226; 46 U.S.C.; 33 CFR 1.05–1, 6.01; Department of Homeland Security Delegation No. 0170.1.) The MTSA E:\FR\FM\04JAN1.SGM 04JAN1

Agencies

[Federal Register Volume 72, Number 2 (Thursday, January 4, 2007)]
[Notices]
[Pages 346-347]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-9970]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases, Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Cooperative Research Patnerships 
for Influenza Product Development.
    Date: January 24-25, 2007.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Silver Spring, 8727 Colesville Road, Silver 
Spring, MD 20910.

[[Page 347]]

    Contact Person: Clayton C. Huntley, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIAID/NIH/DHHS, Room 3246, 6700B Rockledge Drive, MSC 
7616, Bethesda, MD 20892-7616, (301) 451-2570 ch405t@nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Study of Antigen Presentation 
Unsolicited P01.
    Date: January 25, 2007.
    Time: 10 a.m. to 1 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Cheryl K. Lapham, PhD, Scientific Review 
Administrator, Scientific Review Program, National Institute of 
Allergy and Infectious Diseases, DEA/NIH/DHHS, 6700-B Rockledge 
Drive, MSC 7616, Room 3127, Bethesda, MD 20892-7616, 301-402-4598, 
Clapham@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Cooperative Research Partnerships 
for Influenza Product Development.
    Date: January 29-30, 2007.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Silver Spring, 8727 Colesville Road, Silver 
Spring, MD 20910.
    Contact Person: Clayton C. Huntley, Phd, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIAID/NIH/DHHS, Room 3246, 6700B Rockledge Drive, MSC 
7616, Bethesda, MD 2089-7616, (301) 451-2570, ch405t@nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Study of Immunoregulation 
Unsolicited P01.
    Date: February 7, 2007.
    Time: 12 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge 6700, 6700B 
Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Cheryl K. Lapham, PhD, Scientific Review 
Administrator, Scientific Review Program, National Institute of 
Allergy and Infectious Diseases, DEA/NIH/DHHS, 6700-B Rockledge 
Drive MSC 7616, Room 3127, Bethesda, MD 20892-7616, 301-402-4598, 
clapham@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Safety Evaluation of Anti-Infective 
Agents.
    Date: February 12, 2007.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda North Marriot Hotel, 5701 Marinelli Road, North 
Bethesda, MD 20852.
    Contact Person: Quirijn Vos, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, National Institutes of Health/NIAID, 6700B Rockledge 
Drive, MSC 7616, Bethesda, MD 20892-7616, 301-496-2550, 
qvos@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: December 26, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-9970 Filed 1-3-07; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.